Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells (2014)
- Authors:
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Campos, Paula de Melo - Universidade Estadual de Campinas (UNICAMP)
- Favaro, Patricia - Universidade Estadual de Campinas (UNICAMP)
- Lazarini, Mariana - Universidade Estadual de Campinas (UNICAMP)
- Lorand-Metze, Irene - Universidade Estadual de Campinas (UNICAMP)
- Costa, Fernando Ferreira - Universidade Estadual de Campinas (UNICAMP)
- Saad, Sara Teresinha Olalla - Universidade Estadual de Campinas (UNICAMP)
- Traina, Fabiola
- Machado Neto, João Agostinho - Universidade Estadual de Campinas (UNICAMP)
- Autor USP: TRAINA, FABÍOLA - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.leukres.2013.11.013
- Subjects: PROLIFERAÇÃO CELULAR; LEUCEMIA MIELOIDE AGUDA; CÉLULAS CULTIVADAS DE TUMOR
- Language: Inglês
- Imprenta:
- Publisher place: Kidlington
- Date published: 2014
- Source:
- Título do periódico: Leukemia Research
- ISSN: 0145-2126
- Volume/Número/Paginação/Ano: v. 38, n. 2, p. 251-257, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MACHADO NETO, João Agostinho et al. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, v. 38, n. 2, p. 251-257, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.11.013. Acesso em: 23 abr. 2024. -
APA
Machado Neto, J. A., Campos, P. de M., Favaro, P., Lazarini, M., Lorand-Metze, I., Costa, F. F., et al. (2014). Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells. Leukemia Research, 38( 2), 251-257. doi:10.1016/j.leukres.2013.11.013 -
NLM
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013 -
Vancouver
Machado Neto JA, Campos P de M, Favaro P, Lazarini M, Lorand-Metze I, Costa FF, Saad STO, Traina F. Stathmin 1 is involved in the highly proliferative phenotype of high-risk myelodysplastic syndromes and acute leukemia cells [Internet]. Leukemia Research. 2014 ; 38( 2): 251-257.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.leukres.2013.11.013 - FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation
- Increased inflammatory markers and their correlations to clinical complications in hemoglobin SC disease
- YAP1 expression in myelodysplastic syndromes and acute leukemias. [Carta]
- ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells
- Differential profile of PIP4K2A expression in hematological malignancies
- Abnormal Hedgehog pathway in myelodysplastic syndrome and its impact on patients' outcome. [Carta]
- Key endothelial cell angiogenic mechanisms are stimulated by the circulating milieu in sickle cell disease and attenuated by hydroxyurea
- IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms
- Padronização da investigação laboratorial de anticorpos dirigidos contra fármacos em doadores de sangue e pacientes com anemia hemolítica imune
- Hydroxyurea therapy reduces the hypercoagulability state in a sickle cell mouse model
Informações sobre o DOI: 10.1016/j.leukres.2013.11.013 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
